29.11 
0.19(0.65%) May 23, 4:00PM EDT|After Hours
:
29.14 0.03 (0.10%) May 23, 7:59PM EDT
| Prev Close: | 29.30 |
|---|
| Open: | 29.08 |
|---|
| Bid: | 29.12 x 200 |
|---|
| Ask: | 29.14 x 1900 |
|---|
| 1y Target Est: | 31.47 |
|---|
| Beta: | 0.81 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 28.85 - 29.33 |
|---|
| 52wk Range: | 21.40 - 31.15 |
|---|
| Volume: | 51,707,183 |
|---|
| Avg Vol (3m): | 33,843,100 |
|---|
| Market Cap: | 206.48B |
|---|
| P/E (ttm): | 13.93 |
|---|
| EPS (ttm): | 2.09 |
|---|
| Div & Yield: | 0.96 (3.30%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Pfizer Halts Inotuzumab StudyZacks(Thu, May 23)
- Final Glance: Pharmaceuticals companiesAP(Thu, May 23)
- J&J expects 10-plus new drug applications by 2017AP(Thu, May 23)
- 5 Stalwarts Loved by Advanced Investment Partnersat Motley Fool(Thu, May 23)
- Midday Glance: Pharmaceuticals companiesAP(Thu, May 23)
- 3 Stocks Dragging In The Drugs Industryat TheStreet(Thu, May 23)
- Another Look At Marketing Vs. R&D In Pharmaat Seeking Alpha(Thu, May 23)
- Early Glance: Pharmaceuticals companiesAP(Thu, May 23)
- J&J: We're Creaming Medivation, Boehringer, Bristol And Pfizerat Forbes(Thu, May 23)
- Merck's Magic Sleeping Pills Wake Up Big Pharmaat Bloomberg(Thu, May 23)
- Lpath Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEPGlobeNewswire(Thu, May 23)
- Pharma Continues To Seek External R&D Funding, This Time From The Governmentat Forbes(Thu, May 23)
- Today's Market News To Trade On: 5 Stocks Moving On Newsat Seeking Alpha(Thu, May 23)
- Pfizer takes its shot at a vaccine for evasive superbugReuters(Thu, May 23)
- Ireland says will not be U.S. 'whipping boy' on taxReuters(Wed, May 22)
Key Statistics
| Forward P/E (1 yr): | 12.39 |
|---|
| P/S (ttm): | 3.61 |
|---|
| Ex-Dividend Date: | 08-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.21 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.58 |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | 4.78 |
|---|
Business Summary
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care phys...
View More